According to GuruFocus Insider Data, the recent CFO sales were: H&R Block Inc. (HRB, Financial), DISH Network Corp. (DISH, Financial), and Alexion Pharmaceuticals Inc. (ALXN, Financial).
H&R Block Inc.: CFO Gregory J Macfarlane sold 265,778 shares
On Dec. 29, Macfarlane sold 265,778 shares at an average price of $33.51. The price of the stock has decreased by 0.6%. H&R Block Inc. has a market cap of $7.86 billion and its shares were traded at around $33.31. The company has a P/E ratio of 21.30 and P/S ratio of 3.04 with a dividend yield of 2.40%. Over the past 10 years, H&R Block Inc. had an annual average earnings growth of 3.80%.
H&R Block announced its 2015 second-quarter results with revenues of $128 million and gross losses of $98 million; the net loss was $145.01 million. The 2015 total revenue was $3 billion, a 2% increase from the 2014 total revenue. The 2015 gross profit was $1.75 billion, a 0.5% increase from the 2014 gross profit. The 2015 net income was $473.66 million.
On Dec. 16, Chief Accounting and Risk Officer Jeffrey Brown sold 50,000 shares at an average price of $33.3. The price of the stock has increased by 0.03%. On Dec. 10, President of US Tax Product Jason Houseworth sold 63,375 shares at an average price of $32.54. The price of the stock has increased by 2.37%.
DISH Network Corp: SVP and CFO Steven E Swain sold 2,000 shares
On Sept. 30, Swain sold 2,000 shares at an average price of $56.89. The price of the stock has increased by 0.51%. Dish Network has a market cap of $26.49 billion and its shares were traded at around $57.18. The company has a P/E ratio of 20.70 and P/S ratio of 1.77. Over the past 10 years, Dish Network Corp had an annual average earnings growth of 5.80%.
Dish Network Corp announced its 2015 third-quarter results with revenues of $3.73 billion and gross profit of $880.57 million; the net income was $196.48 million. The 2014 total revenue was $14.64 billion, a 5% increase from the 2013 total revenue. The 2014 gross profit was $3.72 billion, a 3% increase from the 2013 gross profit. The 2014 net income was $944.69 million.
On Dec. 29, Senior Advisor David K Moskowitz sold 300,000 shares at an average price of $57.89. The price of the stock has decreased by 1.23%. On Nov. 18, EVP of Corporate Development Thomas A. Cullen sold 80,000 shares at an average price of $63.33. The price of the stock has decreased by 9.71%. On Oct. 1, SVP and Corporate Controller Paul W Orban sold 130 shares at an average price of $58.51. The price of the stock has decreased by 2.27%.
Alexion Pharmaceuticals Inc.: EVP and CFO Vikas Sinha sold 675 shares
On Aug. 4, EVP and CFO Vikas Sinha sold 675 shares at an average price of $196.52. The price of the stock has decreased by 2.94%. Alexion Pharmaceuticals Inc. has a market cap of $42.98 billion and its shares were traded at around $190.75. The company has a P/E ratio of 155.20 and P/S ratio of 15.90. Over the past five years, Alexion Pharmaceuticals Inc. had an annual average earnings growth of 52.30%.
Alexion Pharmaceuticals announced its 2015 third-quarter results with revenues of $666.64 million and gross profit of $612.58 million. The 2014 total revenue was $2.23 billion, a 44% increase from the 2013 total revenue. The 2014 gross profit was $2.06 billion, a 50% increase from the 2013 gross profit. The 2014 net income was $656.91 million.
On Aug. 7, CEO David Hallal sold 329 shares at an average price of $190.01. The price of the stock has increased by 0.39%. On Dec. 29, Director Leonard Bell sold 35,000 shares at an average price of $190.66. The price of the stock has increased by 0.05%. On Dec. 11, Director R Douglas Norby sold 45,442 shares at an average price of $187.71. The price of the stock has increased by 1.62%.
